Published in Hepatitis Weekly, July 10th, 2006
U.V. Gentilucci and colleagues, University of Rome Campus of Biomedicine, wrote that the study was done "to evaluate the cytoplasmic and nuclear expression of hepatic growth hormone receptor (GHR) in different stages (S-0, S-1, S-3 and S-4, according to Knodell's classification) of chronic liver disease (CLD) and in hepatocellular carcinoma (HCC)."
"Liver specimens from 31 patients with hepatitis C virus-related CLD, five patients with HCC and nine controls were examined for...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.